cal findings were retrospectively reexamined. The study protocol was approved by the local ethics committee. In addition, a PubMed search revealed 77 cases reported in the literature, which we then analyzed (see Table 4 ).
All our patients with IVC were primarily examined at referring hospitals and later sent to our institution for further evaluation and treatment. They underwent CT and MR imaging prior to admittance to our department. We classified cavernomas located in the ventricles into the following 3 main groups: Group A, "true" intraventricular lesions attached to ependyma or choroid plexus but that do not extend outside the ventricle wall; Group B, lesions with an intraparenchymal part but no more than one-half of the volume; and Group C, paraventricular lesions with only a small portion (less than half of the volume) located in the ventricle. We did not include Group C cavernomas in present study.
In patients with intraventricular hemorrhage, MR imaging was performed only several months after the resorption of extravasated blood, aiming at a more definitive preoperative diagnosis. Only the patient in Case 12 underwent CT scanning, MR imaging, and digital subtraction angiography immediately after presenting with a 5-cm-diameter hematoma to exclude AVM or tumor ( Fig. 1 ). Due to progressive somnolence, 1 patient underwent surgery 2 days after the bleeding. Standard T1-and T2-weighted imaging with a T2*-weighted gradient echo sequence was performed. Lesions were classified according to the Zabramski classification scheme. 73 In total of 5 cases (42%), digital subtraction angiography was performed to exclude AVMs.
In 3 patients the IVC was not removed. The patient in Case 1 (Table 1 ) underwent only a shunt procedure for obstructive hydrocephalus caused by an unrelated aqueductal stenosis and experienced a significant improvement in symptoms; this patient refused removal of the cavernoma. One patient (Case 11) with multiple supratentorial cavernomas and another (Case 9) with a right trigonal cavernoma refused to undergo surgery. Of all 12 patients, microsurgical excision of IVC was performed in 9 (75%). There were 5 men and 4 women in this group. The median age at operation was 49 years (range 20-65 years). All patients presented primarily with acute headache; 2 patients with a fourth ventricle cavernoma suffered from diplopia and facial nerve paresis. All microsurgically treated patients underwent routine CT imaging in the immediate postoperative period. In 1 patient who underwent surgery (Case 7), follow-up MR imaging was performed after several months to exclude a cavernoma residual. Furthermore, in 2 of the 3 conservatively treated patients, MR imaging was performed at our department at 1 year after the primary diagnosis.
In addition to the routine postoperative outpatient visit at 3 months, all patients were interviewed in 2008 by using mailed health questionnaires. Patients' general outcome was assessed using the Glasgow Outcome Scale. 31 Statistical analysis was carried out (by J.K.) using SPSS 15.0 software (SPSS, Inc.). Clinical characteristics are presented as percentages for categorical variables and as medians for continuous variables.
Results

Patients and Symptoms
Clinical data on the 12 patients are summarized in Table 1 . There were 8 male (67%) and 4 female (33%) patients, thus showing a male preponderance of 2:1. The median patient age at admission was 47 years (range 15-66 years). As a presenting symptom, 11 patients (92%) had an acute mild to severe headache accompanied by nausea and vomiting. Three patients (27%) with a cavernoma in the fourth ventricle had CN deficits (paresis of CNs III, VI, and VII, separately or in various combinations). Four patients (36%) had hydrocephalus at admission, but shunt treatment was necessary in only 1 patient (Case 1). None of the patients had a history of epileptic seizures, except for the patient in Case 5, who had a single epileptic seizure after partial resection of the cavernoma; after a reoperation and removal of the cavernoma, the patient was seizure-free.
Eight patients (67%) suffered acute deterioration due to hemorrhage from the cavernoma, which was confirmed by CT scanning and a lumbar puncture. In all but 1 patient (Case 12), bleeding was clinically and radiologically mild, and no patient required emergency surgery. The patient in Case 12 had a large hematoma in the lateral ventricle that ruptured into the basal ganglia area, and he presented with contralateral hemiparesis and progressive somnolence, which warranted emergency surgery.
Rebleeding occurred in 3 patients (Cases 4, 5, and 6) before lesionectomy and in 2 conservatively treated patients (Cases 9 and 11). Two rebleedings occurred in 1 patient (Case 5) after partial resection of the lesion in the left lateral ventricle. Therefore, 8 rebleedings occurred in 5 patients (42%) during a median time of 0.4 years (range 0.1-5 years). None of the rehemorrhages caused severe neurological deterioration, but the patients were admitted for short-term hospitalization at referring hospitals. Later, patients were admitted to our department in stable condition for further evaluation and treatment.
Imaging and Location of the Cavernomas
The lesions, their location, and their size are presented in Table 2 . In 11 patients, the IVCs were Zabramski Type II lesions, and in 1 patient (Case 12) it was Type I. In comparison with the Group B cavernomas, the typical perifocal hemosiderotic rim in Group A cavernomas was thinner or absent, and the lesion's core was less heterogeneous. In total, 10 lesions were partially buried in the surrounding brain belonging to Group B. In addition to an IVC, 3 patients had multiple Type IV intraparenchymal cavernomas seen only on T2*-weighted gradient echo sequences. In the patients in Cases 5 and 8, the lesion was initially interpreted as a choroid plexus papilloma and ependymoma, respectively, but a later histological examination confirmed it to be a cavernoma. In other patients, the lesions were initially thought to be IVCs on radiological diagnoses.
Six of the 11 IVCs were located in the lateral ventricle, mainly on the left side (Fig. 2) . In 3 cases, the cavernomas were located on the lateral side of the body and atrium (trigonum) of the lateral ventricle. One patient had a lesion in the occipital horn of the lateral ventricle attached to the choroid plexus (Fig. 3) , and 2 patients had IVCs in the frontal horn attached to the ependyma. One IVC was in the third ventricle without radiological signs of enlarged ventricles. In 5 patients (45%), the IVC was found in the fourth ventricle, typically in the medial part of the floor (Fig. 4) .
The median size of the IVCs was 15 mm (range 10-30 mm). The IVCs in the lateral ventricles (median size 12 mm) were smaller than those in the fourth ventricle (median size 17 mm). The median size of associated intraparenchymal cavernomas was 3 mm. Two patients, each with a cavernoma in the lateral ventricle, had an associated, MR imaging-confirmed venous anomaly. 
Treatment
Nine patients underwent excision of the IVC to prevent rebleedings or to eliminate the mass effect, or both. In 7 patients, surgery was performed by the senior author (J.H.). The median time from diagnosis to surgery was 1.3 years (range 2 days-11 years). One patient (Case 12) underwent emergency surgery because of a large intraventricular/intracerebral hematoma and progressive somnolence. Of the surgcially treated IVCs, 3 were located in the lateral, 1 in the third, and 5 in the fourth ventricles. In 2 patients (Cases 3 and 12), the lesion in the left frontal horn was exposed by paramedian craniotomy through an interhemispheric-transcallosal approach. One patient (Case 5) with a cavernoma of the atrium of the left lateral ventricle underwent surgery 3 times. Initially, he underwent diagnostic stereotactic biopsy for an undefined lesion after suffering intraventricular hemorrhage. Two months later, he presented with intraventricular rebleeding and underwent a parietooccipital craniotomy and a transcortical approach to the ventricle. Four months after the first resection, he again suffered from worsening headaches; a CT scan showed intracerebral/intraventricular bleeding, which was removed together with a cavernoma remnant. An MR imaging study performed 7 years after surgery still showed a small cavernoma remnant, but the patient refused further surgery.
One patient (Case 7) with a cavernoma in the third ventricle underwent a frontoparietal paramedian craniotomy and an interhemispheric transcallosal-transseptal approach. In this case, a strongly calcified lesion was evident in the region of the Monro foramen without hydrocephalus; it grew upward into the septum pellucidum cavity, and had to be removed in a piecemeal manner. In 5 patients with fourth ventricle lesions, a median suboccipital craniotomy was performed with the patient in a sitting position. The fourth ventricle was exposed by retraction of the cerebellar tonsils laterally. Extremely gentle dissection of the lesion from the floor of the ventricle was performed. Tiny feeding arteries were coagulated with bipolar forceps under minimal voltage to avoid inadvertent damage to the subependymal vessels supplying the brainstem. In all these patients, the cavernoma was partially buried in the brainstem, necessitating more invasive removal.
Postoperative complications are summarized in Table  3 . The patient in Case 5 had postoperative intraventricular bleeding after partial resection of the lesion, which required removal.
Outcome
The median follow-up of the 12 patients was 2 years (range 0.5-20 years), and the total follow-up time was 70 person-years. No patient was lost to follow-up. Age, sex, and a previous hemorrhage had no influence on the outcome. No patient died. Patients with fourth ventricle cav- ernomas had a worse outcome than did those with lateral ventricle lesions ( Table 1) . Five of the 9 patients who underwent surgery were symptom-free at follow-up. The IVCs in the lateral ventricles and in the third ventricle were removed without any new permanent neurological deficits. A new CN deficit was seen postoperatively in 2 patients (Cases 6 and 8) with a fourth ventricle lesion. The patients in Cases 4, 6, 8, and 12 presented with focal neurological deficits before surgery; 1 of these patients (Case 12) had complete recovery of his hemiparesis and had only mild memory disturbances at the 5-year follow-up (Table 3) . One patient (Case 7) had significant memory disturbances in the immediate postoperative period, but these completely resolved at the last follow-up at 1.7 years.
In total, 9 patients (75%) were asymptomatic or had only minor neurological problems at presentation, and 3 (25%) had persistent neurological deficits at the last follow-up; the deficits in 2 patients (CN VI and VII nerve paresis and memory disturbances in Cases 4 and 12, respectively) were present before surgery (Table 3) . No patient had a severe disability.
Discussion
Special Clinical Features
The course of IVCs seems to be relatively benign. Only 1 (1%) of the 77 patients previously reported on died after a rupture of an IVC in the temporal horn of the lateral ventricle, causing severe intraventricular bleeding and intracerebral hematoma (Table 4) . 50 In the literature, 11 patients (14%) presented with intraventricular hemorrhage, which is less than that in our consecutive series of 12 patients; this is most probably due to the low numbers of patients (Table 5 ). In the present series, intraventricular bleeding from an IVC caused no permanent neurological deficits in 11 patients, and only 1 patient had major bleeding that was potentially life-threatening and required emergency treatment.
Of our 12 patients, 5 (45%) had 8 total rehemorrhages soon after the primary hemorrhage, indicating a higher tendency of the IVC to rehemorrhage when compared with cavernomas in other locations. 73 However, in all but 1 neither the rebleedings nor the primary bleedings led to any additional neurological deficits or required emergency surgery. This is also in concordance with the previous reports, in which in majority of cases, rebleedings from IVC caused no significant permanent neurological deficits.
In our series, 4 patients (36%) had hydrocephalus on admission, but only 1 underwent shunt treatment. In the literature, 42% of patients with IVC had a third ventricle lesion, and the majority developed hydrocephalus because of mechanical obstruction, with only 3 patients 23,33,68 presenting with an intraventricular hemorrhage. At the same time, cavernomas of the lateral or fourth ventricle most frequently led to focal neurological deficits as a result of the mass effect on the surrounding brain, with acute impairment after bleeding. In cases of acute hydrocephalus, temporary external ventricular drainage was usually applied before surgical extirpation of the lesion, and in 5 previously reported cases permanent shunt treatment was indicated. 14, 24, 33, 49, 61 In this group, in 4 patients the cavernoma was in the third ventricle, and 1 newborn had a large lesion in the lateral ventricle.
In our series, epileptic disorders occurred in 1 patient (Case 5) but only after partial resection of a lateral ventricle cavernoma, and this patient was seizure-free during follow-up. In previous reports of patients with IVC, epileptic manifestations were more frequent, occurring in 14% and almost exclusively in individuals with a lateral ventricle lesion. The frequency of seizures in patients with IVCs seems to be significantly lower than in patients with intraparenchymal supratentorial cavernomas, of whom > 70% have seizures. 6 This difference can be easily explained by the fact that intraventricular lesions do not lead to the true perilesional intracerebral gliosis and hemosiderosis, which create epileptogenic activity. 5 
Differential Diagnostics
In patients with acute severe headaches, a CT scan is mandatory because of its high sensitivity in detecting fresh hemorrhage. In acute intraventricular bleeding, however, the radiological diagnosis of the IVC is unreliable, and MR imaging is more informative after the resorption of extravasated blood. In our series, MR imaging with MR , severe memory problems were treated with intensive rehabilitation by a neurologist and a neuropsychologist and at follow-up were completely resolved. The patient in Case 12 had only minor memory difficulties at follow-up, which did not limit his normal daily activity. angiography was performed immediately after bleeding only in the patient in Case 12 because of acute neurological deterioration to exclude tumor bleeding. Digital subtraction angiography is also indicated to exclude an AVM when a patient presents with major intracerebral bleeding; however, this is uncommon in individuals with cavernoma. A cavernoma in the ventricle is not always limited by the ependyma and can extend to the surrounding brain, and we classified cavernomas into 3 groups accordingly. Although our classification is offered only on empirical basis, we suppose that in clinical practice, the treatment strategy of the Group C cavernomas seems to be almost similar to the intraparenchymal ones. Thus, we did not include these patients in the present series. An IVC can be interpreted as an intraventricular choroid plexus papilloma, a trigonum meningioma, or an ependymoma (Table 6 ). An IVC does not increase CSF secretion per se, which can be useful in the differential diagnostics of CSF-secreting choroid plexus papillomas in a similar location. 47 Furthermore, IVCs have a reported preponderance of rapid growth, 33 which should be taken into account in differentiating the IVC from the benign trigonum meningiomas. Intraventricular ependymomas usually occur in children, and IVCs are more typical in adults. 64 
Treatment of the IVC, Morbidity, and Mortality
Still, little is known about natural history of the IVC. The lack of thorough prospective series and long-term follow-up makes decision-making in the treatment of IVCs difficult. Surgery is advocated when rehemorrhages are frequent, and the mass-effect causes progressive neurological deficits. In our series, repetitive rehemorrhages accompanied by acute headaches with nausea and vomiting occurred often and caused discomfort. Furthermore, patients with an IVC in the fourth ventricle developed CN deficits because of the mass effect. Major bleeding occurred in only in 1 of our patients, but although being uncommon, it demonstrated the risk of severe hemorrhage from a cavernoma, thus advocating surgical treatment of the IVC. Four of our 9 patients who underwent surgery had neurological deficits that persisted at follow-up, but 2 of them existed before surgery (Table 3 ). In the previous reports, 68 patients (88%) with IVC underwent surgery, and 18 (24%) of them presented with persistent neurological deficit in follow-up. Notably, 5 patients (7%) died of surgical complications. 18, 21, 33, 61, 64 In estimation of operative risks, the IVC's location is relevant. Surgery for an IVC in the lateral or third ventricle is safer than that in the fourth ventricle. Patients with cavernomas close to the brainstem frequently present preoperatively with CN deficits as a sign of brainstem damage. Thus, surgery in this already affected region can worsen neurological status and cause new deficits, even after minimal manipulation. These deficits have significant recovery potential, however, and many of them improve after a long recovery period. 57 Increased morbidity in our series may thus be explained by our rather short follow-up time and also by the fact that 5 (63%) of the 8 patients who underwent surgery had a lesion in the fourth ventricle, where surgical removal is known to be with higher risks.
Conclusions
In our series of 12 consecutive patients with IVC treated at 1 institution, we found a high tendency of the IVC to rebleed in a short period of time after the first event.
Although not life-threatening in most of the patients, the hemorrhage caused symptoms-mainly headache and nausea-that led to short-term hospitalization. Surgery is indicated when rebleedings are frequent, and the mass effect causes progressive neurological deterioration. Modern microsurgical techniques allow safe removal of the IVC, but surgery on cavernomas in the fourth ventricle carries increased risk of postoperative CN deficits. 
Disclaimer
